R1 RCM Inc header image

R1 RCM Inc

R1 RCM Rg

Equity

ISIN null / Valor 119376523

NASDAQ (2024-11-18)
USD 14.31+0.07%

R1 RCM Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

R1 RCM Inc. is a provider of technology-enabled revenue cycle management (RCM) services for the healthcare industry. The company offers a comprehensive suite of solutions aimed at enhancing financial performance and patient care for healthcare providers. These services include revenue recovery, revenue optimization, clinical integrity, and regulatory navigation, all designed to address various aspects of the revenue cycle from ensuring accurate documentation and coding to optimizing reimbursement opportunities and ensuring regulatory compliance. R1 RCM leverages advanced analytics, leading technology, and deep domain expertise to deliver scalable solutions that meet the unique needs of its clients, aiming to improve patient experiences by reducing financial friction and enhancing operational efficiency. The company supports healthcare providers in managing the complexities of the revenue cycle, aiming to drive sustainable financial results and better patient care outcomes.

Summarized from source with an LLMView SourceSector: Finance

Latest Results (24.12.2024):

Revenue Growth

In the fourth quarter of 2023, R1 RCM Inc. reported a revenue of $575.1 million, marking an increase of $41.8 million or 7.8% compared to the same period in the previous year. For the full year 2023, the company achieved a total revenue of $2,254.2 million, which is an increase of $447.8 million or 24.8% from 2022.

Net Income Improvement

R1 RCM Inc. recorded a GAAP net income of $1.4 million in the fourth quarter of 2023, a significant improvement from a net loss of $36.6 million in the same quarter of the previous year. For the full year 2023, the company reported a GAAP net income of $3.3 million, compared to a net loss of $63.3 million in 2022.

Adjusted EBITDA Increase

The company's adjusted EBITDA for the fourth quarter of 2023 was $167.7 million, representing an increase of $42.1 million or 33.5% compared to the same period last year. For the entire year, R1 RCM Inc. reported an adjusted EBITDA of $614.3 million, up by $190.5 million or 45.0% from 2022.

2024 Financial Outlook

Looking ahead to 2024, R1 RCM Inc. expects to generate revenue between $2,625 million and $2,675 million. The company anticipates a GAAP operating income ranging from $105 million to $135 million and an adjusted EBITDA between $650 million and $670 million.

Strategic Initiatives

R1 RCM Inc. has focused on strengthening its technology platform by driving innovation through generative AI and enhancing its global infrastructure. The company aims to leverage its capabilities to deploy flexible models that meet customers' needs in their revenue cycle journey, positioning itself for long-term sustainable growth and improved financial performance.

Summarized from source with an LLMView Source

Key figures

34.1%1Y
-43.4%3Y
13.8%5Y

Performance

0.76%1Y
67.8%3Y
55.9%5Y

Volatility

Market cap

6044 M

Market cap (USD)

Daily traded volume (Shares)

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

TFS Financial Corp
TFS Financial Corp TFS Financial Corp Valor: 3072102
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.49%USD 14.27
MPC Muenchmeyer Petersen Capital AG
MPC Muenchmeyer Petersen Capital AG MPC Muenchmeyer Petersen Capital AG Valor: 20991409
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.07%EUR 4.94
Structure Therapeutics Incorporation
Structure Therapeutics Incorporation Structure Therapeutics Incorporation Valor: 124807608
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.86%USD 35.30
WillScot Holdings Corp
WillScot Holdings Corp WillScot Holdings Corp Valor: 55821381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.80%USD 17.75
Bank of New York Mellon Corp
Bank of New York Mellon Corp Bank of New York Mellon Corp Valor: 2824731
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.54%USD 108.07
Tradeweb Markets Inc
Tradeweb Markets Inc Tradeweb Markets Inc Valor: 46837409
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.28%USD 105.10
Medical Properties Trust Inc
Medical Properties Trust Inc Medical Properties Trust Inc Valor: 1830604
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.38%USD 5.32
DaVita Inc
DaVita Inc DaVita Inc Valor: 1139087
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.63%USD 119.49
Eastgroup Properties Inc
Eastgroup Properties Inc Eastgroup Properties Inc Valor: 647263
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.06%USD 179.90
Brixmor Property Group Inc
Brixmor Property Group Inc Brixmor Property Group Inc Valor: 21937955
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.33%USD 26.04